Mits Healthcare Pvt Ltd
Letrozole (2.5mg)
Letromits 2.5mg Tablet is used to treat breast cancer in post-menopausal women, either alone or with other treatments, and to stop the tumor from spreading to other parts of the body.
Tablet
Letromits 2.5mg Tablet is an aromatase inhibitor that helps treat breast cancer in post-menopausal women. It works by decreasing the amount of estrogen produced in the body, which can slow down or stop the growth of some breast cancers that need estrogen to grow. It may be used alone or with other treatments, such as surgery or radiation.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Letromits 2.5mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Letromits 2.5mg Tablet is an aromatase inhibitor that works by decreasing the amount of estrogen produced in the body. This decrease in estrogen can slow down or stop the growth of some breast cancers that need estrogen to grow.
You have been prescribed Letromits 2.5mg Tablet for the treatment of breast cancer. It can be taken with or without food. Do not drive or do anything requiring concentration until you know how Letromits 2.5mg Tablet affects you. It may cause increased sweating and hot flushes. Try to keep cool by wearing light and airy clothes. Your doctor may monitor your cholesterol level and bone mineral density (BMD) regularly as Letromits 2.5mg Tablet can alter their levels.
Letromits 2.5mg Tablet is an aromatase inhibitor used to treat breast cancer in postmenopausal women whose periods have stopped, either due to natural menopause or after surgery or chemotherapy.
Letromits 2.5mg Tablet is also known as an anti-estrogen drug. It works by reducing the production of estrogen in your body by blocking the enzyme aromatase, which is responsible for producing estrogen. Estrogen contributes to the growth and spread of certain types of breast cancer. By lowering estrogen levels, Letromits 2.5mg Tablet may prevent or slow down cancer progression.
The duration of treatment depends on the stage and extent of your breast tumor: - For advanced breast tumors with spread to other parts of the body, treatment may continue until tumor progression is observed. - In cases where Letromits 2.5mg Tablet is given after tamoxifen (another anti-estrogen) or surgery, it should be taken for 5 years, or until a recurrence occurs, whichever comes first. - Sequential treatment can also be used: 2 years of Letromits 2.5mg Tablet followed by 3 years of tamoxifen.
Yes, you can take irbesartan and Letromits 2.5mg Tablet together. However, it is important to monitor your blood pressure regularly as Letromits 2.5mg Tablet may increase it. Consult your doctor if you face difficulty controlling your blood pressure.
While uncommon, Letromits 2.5mg Tablet can cause a cataract. If you experience blurred vision or eye irritation, consult your doctor immediately.
This could be due to hot flushes, a common side effect of Letromits 2.5mg Tablet which happens due to decreased estrogen levels. The frequency of hot flushes decreases as your body adjusts to the medication, but some individuals may continue to experience them and occasional sweating for months after treatment ends. You can discuss this with your doctor who might offer relief if it proves bothersome.
Serious side effects rarely occur and include stroke, angina, heart attack, blood clotting, cataracts, osteoporosis, and severe skin reactions.
Letromits 2.5mg Tablet can lead to a thinning or weakening of bones (osteoporosis) due to decreased estrogen levels in your body. Your doctor may recommend measuring your bone density during and after treatment.
The use of Letromits 2.5mg Tablet for inducing ovulation in women with anovulatory infertility is restricted by the Ministry of Health and Family Welfare.